Stock UNCY UNICYCIVE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Unicycive Therapeutics, Inc.

Equities

UNCY

US90466Y1038

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-15 pm EDT 		5-day change 1st Jan Change
1.08 USD -0.92% Intraday chart for Unicycive Therapeutics, Inc. -4.42% +24.47%
May. 13 Unicycive Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 04 Piper Sandler Initiates Coverage on Unicycive Therapeutics With Overweight Rating, $9 Price Target MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
UNICYCIVE THERAPEUTICS, INC. Stock Unicycive Therapeutics, Inc.
 40.99M - - - - -
MODERNA, INC. Stock Moderna, Inc.
 49.18B -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 42.11B
LONZA GROUP AG Stock Lonza Group AG
 40.37B
CELLTRION, INC. Stock Celltrion, Inc.
 28.85B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.09B
  1. Stock Market
  2. Equities
  3. UNCY Stock
  4. Charts Unicycive Therapeutics, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW